FY 2025 NIST Small Business Innovation Research Program Phase I
ID: 356882Type: Posted
Overview

Buyer

National Institute of Standards and Technology (DOC-NIST)

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356882
Timeline
    Description

    The National Institute of Standards and Technology (NIST) is inviting applications for the FY 2025 Small Business Innovation Research (SBIR) Program Phase I, aimed at supporting small businesses in exploring the feasibility of innovative technologies for commercial viability. Eligible applicants must qualify as Small Business Concerns, with the principal investigator primarily employed by the business, ensuring a strong commitment to the proposed research. This program is critical for fostering technological innovation, particularly in energy efficiency and renewable energy, and serves as a pathway for further funding in subsequent phases of research and commercialization. Up to ten awards of up to $100,000 each will be granted, with applications due by December 27, 2024. For more information, interested parties can contact Misty L Roosa at grants@nist.gov.

    Point(s) of Contact
    grants@nist.gov
    Files
    Title
    Posted
    FY25.pdf
    The FY 2025 NIST Small Business Innovation Research (SBIR) Program Phase I Notice of Funding Opportunity invites small business applications for innovative technologies aiming for commercial viability. NIST seeks to stimulate technological innovation and foster participation from socially and economically disadvantaged businesses. Up to ten awards will be granted, each up to $100,000, with a deadline for applications set for December 27, 2024. Eligible applicants must qualify as Small Business Concerns, with the principal investigator primarily employed by the business. The program operates in three phases: Phase I focuses on feasibility, Phase II on research and development, and Phase III on commercialization. Phase I awards are crucial for demonstrating the potential for further funding in Phase II. The program prioritizes energy efficiency and renewable energy efforts, aligning research with NIST’s technical goals. Applicants must adhere to new cybersecurity scrutiny and disclose financial affiliations to foreign entities. This initiative exemplifies the government’s commitment to enhancing innovation through collaboration between private businesses and federal resources.
    Similar Opportunities
    NOAA Small Business Innovation Research (SBIR) Program- FY25 Phase I
    Active
    DOC NOAA - ERA Production
    The National Oceanic and Atmospheric Administration (NOAA) is inviting small businesses to submit proposals for the Fiscal Year 2025 Small Business Innovation Research (SBIR) Program, specifically for Phase I funding. This program aims to stimulate technological innovation and enhance the role of small businesses in meeting federal research and development needs, with a focus on projects that can be commercialized. Eligible applicants must conduct primary research in the U.S. and demonstrate scientific merit and market potential in their proposals, particularly in areas related to NOAA's mission, with an emphasis on participation from disadvantaged and women-owned businesses. The deadline for submitting Phase I applications is January 15, 2025, with awards ranging from $0 to $190,000, and an estimated total program funding of $6,650,000 available for approximately 35 awards. For further inquiries, applicants can contact Michele Pollard at noaa.sbir@noaa.gov or visit the NOAA Tech Partnership Office website for additional information.
    PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), has announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) Grant Applications. This funding opportunity invites eligible U.S. small businesses to submit applications for Phase I, Phase II, Fast-Track, and Direct to Phase II projects that align with the research missions of the NIH, CDC, and FDA, with a focus on stimulating technological innovation and commercialization of federal R&D investments. Notably, applications must not include clinical trials, and funding levels are capped at $306,872 for Phase I and up to $2,045,816 for Phase II, with a submission deadline of April 5, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Measurement Science and Engineering (MSE) Research Grant Programs
    Active
    National Institute of Standards and Technology
    The National Institute of Standards and Technology (NIST) is offering the Measurement Science and Engineering (MSE) Research Grant Programs for Fiscal Year 2024, aimed at advancing measurement science and standards across various fields such as biotechnology, advanced manufacturing, and cybersecurity. This funding opportunity, identified as NOFO Number 2024-NIST-MSE-01, is open to a wide range of non-Federal entities, including institutions of higher education, non-profit organizations, for-profit organizations, state and local governments, and Indian tribes, with no cost-sharing requirement for applicants. The grants are intended to foster collaboration, workforce development, and technical innovation, thereby enhancing U.S. competitiveness and promoting diversity in research. Interested applicants can submit their proposals on a rolling basis via Grants.gov, with the application deadline set for March 5, 2026. For further inquiries, applicants may contact Misty Roosa at Grants@nist.gov.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) Grant Applications, inviting eligible U.S. small businesses to submit proposals for innovative projects that align with NIH's research and development mission. This funding opportunity, identified as PA-24-247, specifically excludes clinical trials and aims to foster collaboration between small businesses and research institutions to advance technology development in health-related fields. Eligible applicants must be for-profit small businesses based in the U.S., with budget limits set at $306,872 for Phase I and $2,045,816 for Phase II awards. The application deadline is April 5, 2025, with an initial submission date of September 5, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    MEP Center State Competition
    Active
    National Institute of Standards and Technology
    The National Institute of Standards and Technology (NIST) is inviting applications for the MEP Center State Competition, aimed at establishing and operating Manufacturing Extension Partnership (MEP) Centers in select states to enhance support for small and mid-sized manufacturers. Eligible applicants include U.S.-based nonprofit institutions, institutions of higher education, and various levels of government, with a requirement for a minimum annual cost share of 50%. This initiative is crucial for boosting manufacturing efficiency and competitiveness through services such as technology integration, workforce development, and market expansion. Applications are due by January 9, 2025, with a total of 11 awards expected, and interested parties can reach out to Misty L Roosa at grants@nist.gov for further information.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)" aimed at supporting Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders. This initiative encourages applications for Phase I and II studies focusing on drugs, biologics, devices, and therapies that align with the mission of the National Institute of Neurological Disorders and Stroke (NINDS), emphasizing the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster innovation. The maximum funding amounts are $295,924 for Phase I and $1,972,828 for Phase II projects, with applications required to demonstrate readiness for eventual FDA regulatory approval. Interested applicants can begin submitting proposals on December 5, 2023, with the application deadline set for September 5, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) have announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) grant applications, specifically requiring clinical trials. This funding opportunity is aimed at U.S. small businesses with the necessary research capabilities to contribute to the missions of the NIH and CDC, encouraging innovation and the commercial viability of health technologies. Eligible applicants can receive funding up to $306,872 for Phase I and $2,045,816 for Phase II, with a submission deadline of April 5, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-246.html.
    NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) to support pre-clinical research aimed at bridging funding gaps that impede the commercialization of medical biotechnology products. This funding opportunity specifically targets previously funded SBIR or STTR Phase II projects, with the objective of advancing products or technologies that require federal regulatory approval, while fostering partnerships between small businesses and external investors to enhance commercialization prospects. Applicants are encouraged to secure independent third-party funding that equals or exceeds one-third of the requested NINDS funds, and must include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in the research environment. The application deadline is April 5, 2027, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-222.html.
    NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NeuroNEXT Small Business Innovation in Clinical Trials," aimed at encouraging small businesses to conduct exploratory clinical trials of investigational agents related to neurological disorders. This initiative seeks applications for Phase II Small Business Innovation Research (SBIR) projects, with a budget of up to $3 million over five years, focusing on trials that align with the strategic plan of the National Institute of Neurological Disorders and Stroke (NINDS). The program is designed to foster public-private partnerships to enhance the development and commercialization of innovative therapies, ultimately improving clinical outcomes in neuroscience research. Interested applicants must adhere to a Community Engagement and Research Inclusion (CERI) plan, with the first application deadline set for January 5, 2025, and additional deadlines throughout 2026 and 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the PHS 2024-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) grant applications, inviting eligible U.S. small businesses to submit proposals that include at least one clinical trial. This funding opportunity aims to support research and development projects that align with the scientific missions of participating NIH Institutes and Centers, emphasizing the importance of innovation in health-related technologies. Eligible applicants must be U.S.-based small businesses with majority ownership by U.S. citizens or resident aliens, and the grants provide funding caps of up to $306,872 for Phase I and $2,045,816 for Phase II projects. Interested parties should note that the application deadline is April 5, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.